Bicillin Cr Injection, Suspension
Product Images NDC 60793-600

7 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bicillin Cr (NDC 60793-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure1 (Bicillin 01)

Chemstructure1 (Bicillin 01)
Chemical structure diagram showing the molecular structure of penicillin G benzathine and penicillin G procaine. The diagram includes detailed ring structures and various functional groups relevant to the active ingredients in BICILLIN CR injection suspension.*
FDA Label Image

Chemstructure2 (Bicillin 02)

Chemstructure2 (Bicillin 02)
Chemical structure of penicillin G benzathine and penicillin G procaine as shown in the diagram, including molecular components and bonds forming the active ingredients.*
FDA Label Image

Logo (Bicillin 03)

Logo (Bicillin 03)
Packaging label for BICILLIN CR injection suspension, intramuscular. The label shows the Pfizer logo with the text "Injectables" and distribution information indicating it is distributed by Pfizer Inc, New York, NY 10017. No dosage or strength details are visible.*
FDA Label Image

Principal Display Panel (1 Inch Syringe Label)

Principal Display Panel (1 Inch Syringe Label)
BICILLIN C-R injection, suspension label showing 1,200,000 units per 2 mL strength of penicillin G benzathine and penicillin G procaine. The label includes warnings such as 'Not for the Treatment of Syphilis' and 'For Deep Intramuscular Injection Only.' Distributed by Pfizer Inc, New York, NY.*
FDA Label Image

Principal Display Panel (10 1 Inch Syringe Carton)

Principal Display Panel (10 1 Inch Syringe Carton)
Bicillin C-R injection, suspension containing penicillin G benzathine and penicillin G procaine, 1,200,000 units per 2 mL. The packaging is for ten 2 mL syringes intended for deep intramuscular injection and pediatric use. The product is distributed by Pfizer Inc and includes warnings about route of administration and use limitations.*
FDA Label Image

Principal Display Panel (1-1/2 Inch Syringe Label)

Principal Display Panel (1-1/2 Inch Syringe Label)
Label for BICILLIN CR injection suspension, containing penicillin G benzathine and penicillin G procaine, with a strength of 1,200,000 units per 2 mL. The label indicates it is for deep intramuscular injection only and includes warnings about non-use for syphilis treatment and fatality if given by other routes. Distributed by Pfizer Inc.*
FDA Label Image

Principal Display Panel (10 1-1/2 Inch Syringe Carton)

Principal Display Panel (10 1-1/2 Inch Syringe Carton)
Bicillin C-R injectable suspension labeled with 1,200,000 units per 2 mL containing penicillin G benzathine and penicillin G procaine. The label states it is for deep intramuscular injection only, distributed by Pfizer Inc. The package is for ten 2 mL syringes, includes a 21 gauge, thin-wall 1 ½ inch needle, and has warnings about fatality if given by other routes and not for treatment of syphilis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.